A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model
about
Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infectionApproaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotypeTreatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS).Management of Shiga toxin-associated Escherichia coli-induced haemolytic uraemic syndrome: randomized clinical trials are needed.Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.Recent advances in understanding enteric pathogenic Escherichia coli.Mouse models of Escherichia coli O157:H7 infection and shiga toxin injectionFunctional capacity of Shiga-toxin promoter sequences in eukaryotic cells.Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni.A DNA vaccine against Escherichia coli O157:H7.Mutation of the Enterohemorrhagic Escherichia coli Core LPS Biosynthesis Enzyme RfaD Confers Hypersusceptibility to Host Intestinal Innate Immunity In vivoPromoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7.DNA vaccines for targeting bacterial infections.Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome.Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development.Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.
P2860
Q27026551-13EEDE5A-3025-4C4F-AB0F-3DFE35D1C203Q28087714-2B4B5C1D-6EBD-47D2-A28C-AA0F513D0192Q33399468-E2C07BF9-C5FC-4C37-8C06-FE8C8BFBAE79Q33404149-687B539C-3833-4241-86B2-291499776543Q33768681-25D27122-1E29-4AE3-AC7E-3AC4FBB83CFAQ34375210-C80ED486-762D-4356-9AAE-131B6C7F3E46Q34497115-18E5308C-12FD-4F03-88E9-9FD374931FC0Q34603051-650A2302-E17C-4B49-B470-8196AE56AF93Q35887055-0A463041-0246-475E-8A46-A104A37E3021Q36777146-75B67C19-D5CD-47B3-9FC8-CCA90151A0A2Q37170303-42188CE9-7A2E-492A-BA00-1BB50A40FDB6Q37218835-70A8BAA3-D2F8-455E-8E85-4CF572E3308AQ37713379-38880851-77AF-49AE-9DA8-01FC0EBF005DQ37771943-B23E92B6-2D32-477D-B743-1A804EF4238BQ46275241-D3066EFB-7DF9-4F72-B825-19BE10A5C1EDQ53696162-17FD830C-4B94-4454-9D7C-450A0A7998E8Q54380771-80110095-B87B-46AD-81D1-6AB4B4488346
P2860
A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A DNA vaccine encoding the ent ...... challenge in the murine model
@en
A DNA vaccine encoding the ent ...... challenge in the murine model.
@nl
type
label
A DNA vaccine encoding the ent ...... challenge in the murine model
@en
A DNA vaccine encoding the ent ...... challenge in the murine model.
@nl
prefLabel
A DNA vaccine encoding the ent ...... challenge in the murine model
@en
A DNA vaccine encoding the ent ...... challenge in the murine model.
@nl
P2093
P2860
P356
P1476
A DNA vaccine encoding the ent ...... challenge in the murine model
@en
P2093
Leticia V Bentancor
Marcos Bilen
Marina S Palermo
María Victoria Ramos
Romina J Fernández Brando
P2860
P304
P356
10.1128/CVI.00328-08
P577
2009-01-28T00:00:00Z